JP2025542410A5 - - Google Patents
Info
- Publication number
- JP2025542410A5 JP2025542410A5 JP2025537069A JP2025537069A JP2025542410A5 JP 2025542410 A5 JP2025542410 A5 JP 2025542410A5 JP 2025537069 A JP2025537069 A JP 2025537069A JP 2025537069 A JP2025537069 A JP 2025537069A JP 2025542410 A5 JP2025542410 A5 JP 2025542410A5
- Authority
- JP
- Japan
- Prior art keywords
- amyrin
- pharmaceutically acceptable
- pharmaceutical composition
- receptor agonist
- cognitive impairment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP22215958.4 | 2022-12-22 | ||
| EP22215958 | 2022-12-22 | ||
| US18/512,512 | 2023-11-17 | ||
| US18/512,512 US12116388B2 (en) | 2022-12-22 | 2023-11-17 | Amylin receptor agonists |
| PCT/EP2023/087353 WO2024133739A1 (en) | 2022-12-22 | 2023-12-21 | Amylin receptor agonists |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025542410A JP2025542410A (ja) | 2025-12-25 |
| JP2025542410A5 true JP2025542410A5 (https=) | 2026-04-08 |
Family
ID=89542238
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025537069A Pending JP2025542410A (ja) | 2022-12-22 | 2023-12-21 | アミリン受容体作動薬 |
Country Status (12)
| Country | Link |
|---|---|
| EP (1) | EP4638480A1 (https=) |
| JP (1) | JP2025542410A (https=) |
| KR (1) | KR20250127104A (https=) |
| CN (1) | CN120435491A (https=) |
| AU (1) | AU2023411346A1 (https=) |
| CL (1) | CL2025001805A1 (https=) |
| CO (1) | CO2025008319A2 (https=) |
| IL (1) | IL321586A (https=) |
| JO (1) | JOP20250144A1 (https=) |
| MX (1) | MX2025007124A (https=) |
| TW (1) | TW202428309A (https=) |
| WO (1) | WO2024133739A1 (https=) |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1994008006A1 (en) | 1992-09-30 | 1994-04-14 | Zymogenetics, Inc. | Human calcitonin receptor |
| ES2401965T3 (es) | 2009-02-19 | 2013-04-25 | Novo Nordisk A/S | Modificación de Factor VIII |
| JP6121992B2 (ja) | 2011-06-10 | 2017-04-26 | ノヴォ ノルディスク アー／エス | ポリペプチド |
| AR097701A1 (es) * | 2013-09-19 | 2016-04-13 | Zealand Pharma As | Análogos de amilina |
| JP6898518B2 (ja) | 2018-02-02 | 2021-07-07 | ノヴォ ノルディスク アー／エス | Ｇｌｐ−１アゴニスト、ｎ−（８−（２−ヒドロキシベンゾイル）アミノ）カプリル酸の塩及び滑沢剤を含む固形組成物 |
| TWI829687B (zh) | 2018-05-07 | 2024-01-21 | 丹麥商諾佛 儂迪克股份有限公司 | 包含glp-1促效劑與n-(8-(2-羥基苯甲醯基)胺基)辛酸之鹽的固體組成物 |
-
2023
- 2023-12-21 CN CN202380088206.1A patent/CN120435491A/zh active Pending
- 2023-12-21 EP EP23838029.9A patent/EP4638480A1/en active Pending
- 2023-12-21 KR KR1020257023613A patent/KR20250127104A/ko active Pending
- 2023-12-21 WO PCT/EP2023/087353 patent/WO2024133739A1/en not_active Ceased
- 2023-12-21 JP JP2025537069A patent/JP2025542410A/ja active Pending
- 2023-12-21 TW TW112150026A patent/TW202428309A/zh unknown
- 2023-12-21 IL IL321586A patent/IL321586A/en unknown
- 2023-12-21 AU AU2023411346A patent/AU2023411346A1/en active Pending
-
2025
- 2025-06-16 JO JOJO/P/2025/0144A patent/JOP20250144A1/ar unknown
- 2025-06-17 CL CL2025001805A patent/CL2025001805A1/es unknown
- 2025-06-18 MX MX2025007124A patent/MX2025007124A/es unknown
- 2025-06-20 CO CONC2025/0008319A patent/CO2025008319A2/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022096662A5 (https=) | ||
| JP2023156479A5 (https=) | ||
| JP2021063088A5 (https=) | ||
| JP5896601B2 (ja) | セラミド誘導体を用いる多発性嚢胞腎疾患の治療方法 | |
| CN108349904B (zh) | Ppar激动剂、化合物、药物组合物及其使用方法 | |
| CN103998443B (zh) | 具有β2肾上腺素能激动剂及M3毒蕈碱拮抗剂的活性的环己胺衍生物 | |
| JP2023062189A5 (https=) | ||
| JP2024504252A5 (https=) | ||
| JP2014502979A5 (https=) | ||
| JP2017128605A (ja) | 抗ウイルス化合物の固体形態 | |
| CA2676456A1 (en) | Tosylate salt of a therapeutic compound and pharmaceutical compositions thereof | |
| KR20130070629A (ko) | 비정형 항정신병약 및 taar1 작용제를 포함하는 조합물 | |
| BR112017011555B1 (pt) | Formulação farmacêutica compreendendo 2-((1-(2(4- fluorofenil)-2-oxoetil)piperidin-4-il)metil)isoindolin-1- ona e kit | |
| RU2013130879A (ru) | Производные оксазолилметилового эфира в качестве агонистов рецептора alx | |
| JP2024541569A5 (https=) | ||
| JP2021528387A5 (https=) | ||
| JP2024028695A (ja) | 外傷性脳損傷を検出するための組成物および方法 | |
| CN107531753A (zh) | 吡咯烷酰胺衍生物及其制备和使用方法 | |
| WO1998020871A1 (en) | Visceral fat lowering agent | |
| JP2008538583A5 (https=) | ||
| JP2022527618A5 (https=) | ||
| JP2025542410A5 (https=) | ||
| JP2008500378A5 (https=) | ||
| JP2010502585A5 (https=) | ||
| JP2020525413A (ja) | インドール化合物を用いた疼痛又は間質性膀胱炎の治療方法 |